Farshid Dayyani
Professor — Division of Hematology and Oncology, Medicine · University of California
Credentials: · · · · · ·
History
- Present
- 2005–2007
Medical Oncology
- 2002–2005
Internal Medicine
- 1998–2002
Medical School of Munich
Research
The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF
The Journal of Immunology · 2002 · 705 citations
Nature Medicine · 2022 · 560 citations
Systematic review or meta-analysis · Head & Neck Oncology · 2010 · First of 6 authors · Corresponding · 394 citations
19 papers
14 papers
- JV
13 papers
10 papers
9 papers · 8 as a resident
7 papers · 6 as a resident
- DI
7 papers
6 papers
Clinical trials
- 2026–2028
ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu
Principal investigator · Recruiting · Early phase 1
University of California, Irvine
- 2025–2027
Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)
Principal investigator · Recruiting · Phase 1
University of California, Irvine
- 2021–2028
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
Principal investigator · Recruiting · Phase 1
University of California, Irvine
- 2021–2024
Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy
Principal investigator · Completed · Phase 1
University of California, Irvine